43 results on '"Eberhard, A."'
Search Results
2. Telecare for Patients with Type 1 Diabetes and Inadequate Glycemic Control
3. Defending the Con Side: Obesity Paradox Does Not Exist
4. Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients: The Graz Endocrine Causes of Hypertension study
5. Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
6. Antiplatelet Therapy for Every Diabetic Person?
7. Postprandial Hyperglycemia and Glycemic Variability: Should we care?
8. The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
9. Insulin as a First-Line Therapy in Type 2 Diabetes: Should the use of sulfonylureas be halted?
10. C-Reactive Protein in Diabetic and Nondiabetic Patients With Acute Myocardial Infarction
11. Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08)
12. Digenic Inheritance of Hepatocyte Nuclear Factor-1α and -1β With Maturity-Onset Diabetes of the Young, Polycystic Thyroid, and Urogenital Malformations
13. A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir
14. Good Glycemic Control With Flexibility in Timing of Basal Insulin Supply: A 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride
15. Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes
16. Complete Long-Term Recovery of β-Cell Function in Autoimmune Type 1 Diabetes After Insulin Treatment
17. Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: A randomized clinical trial
18. Intensification of Therapeutic Approaches Reduces Mortality in Diabetic Patients With Acute Myocardial Infarction: The Munich registry
19. Glimepiride Treatment and IGF-I in Adolescents With Type 1 Diabetes: A prospective, randomized, double-blind, placebo-controlled study
20. Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart
21. Proinsulin-Specific Autoantibodies Are Relatively Infrequent in Young Offspring With Pre-Type 1 Diabetes
22. Urinary Excretion of Albumin in Adolescents With Type 1 Diabetes: Persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control
23. Circadian Blood Pressure During the Early Course of Type 1 Diabetes: Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults
24. How Can We Improve Prognosis in Diabetic Patients With End-Stage Renal Disease?
25. Successful Treatment With Insulin Analog Lispro in IDDM With Delayed Absorption of Subcutaneously Applied Human Regular Insulin and Complicated Intraperitoneal Insulin Infusion: A case report
26. Objective Assessment of Smoking Habits by Urinary Cotinine Measurement in Adolescents and Young Adults With Type 1 Diabetes: Reliability of reported cigarette consumption and relationship to urinary albumin excretion
27. Influence of Long-Term Glycemic Control on the Development of Cardiac Autonomic Neuropathy in Pediatric Patients with Type I Diabetes
28. Autoantibodies to Sympathetic Ganglia, GAD, or Tyrosine Phosphatase in Long-Term IDDM With and Without ECG-Based Cardiac Autonomic Neuropathy
29. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
30. Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
31. Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
32. Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients
33. Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
34. Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
35. Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
36. New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
37. Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.
38. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers.
39. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique.
40. Low-pigment skin type and predisposition for development of type I diabetes.
41. Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163.
42. Complete long-term recovery of beta-cell function in autoimmune type 1 diabetes after insulin treatment.
43. A case of diabetic pregnancy controlled with a percutaneous access device for intraperitoneal insulin infusion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.